Komori
Share Issuance and Disposal2796Pharmarise Holdings CorporationRetail

Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock-Based Compensation

譲渡制限付株式報酬として、当社が保有する自己株式141,620株を取締役6名に処分し、払込みが完了した。

Worth reading
29Immaterial
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
71801340
¥
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Disposal of treasury shares as restricted stock compensation

Who receives how much141,620Shares

自己株式 141,620株

当社の取締役(社外取締役を除く)6名、141,620株

The lower thin line represents the existing number of shares to which these shares will be added.

¥507 per share
Total issue value71,801,340Yen
Categories and Number of Persons Covered
当社の取締役(社外取締役を除く)6名:141,620株
Payment date
令和7年10月1日
Details of issuance or disposal
ItemDetails
Type of issuance or disposalDisposal of treasury shares as restricted stock compensation
Number of shares to be issued or disposed of自己株式 141,620株
Issue price and disposal price¥507 per share
Total issue value71,801,340円
Payment date令和7年10月1日
Intended allottee当社の取締役(社外取締役を除く)6名、141,620株
Categories and Number of Persons Covered当社の取締役(社外取締役を除く)6名:141,620株
Items this document does not state (21)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

令和7年9月16日開催の取締役会で決議された譲渡制限付株式報酬としての自己株式処分について、払込手続きが完了したため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock-Based Compensation | Pharmarise Holdings Corporation (2796) timely disclosure | Komori